2022-02-22

Modern Healthcare: How is extended genotyping shaping the future of cervical cancer screening?

Modern Healthcare: How is extended genotyping shaping the future of cervical cancer screening?

In this op-ed, Dr. Jeff Andrews, Vice President of Medical Affairs for Integrated Diagnostic Solutions at BD, board-certified obstetrician and gynecologist, former chief medical research advisor for the American Society for Colposcopy and Cervical Pathology, and former professor at Duke University Medical Center and at Vanderbilt University Medical Center, shares his vision.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

Molly Broache, Associate Director, Medical Affairs for US IDS discusses the future of cervical cancer screening
Cervical Cancer | News & Updates
Clinical Lab Products: The Future of Cervical Cancer Screening is Here
Smiling woman smiling while painting
STIs | Vaginitis | Brochures
Vaginitis and STIs: The right treatment begins with the right diagnosis
BD Onclarity™ HPV Assay with extended genotyping
Cervical Cancer | Brochures
BD Onclarity™ HPV Assay with extended genotyping